Showing results (521-530 of 558) with videos related to
Sort By:
Pageof 56
Journal of Geriatric Oncology|June 1, 2026
Screening for poor muscle strength in older Indian patients with solid tumor using SARC-F questionnaire and handgripAnupa Pillai, Anant Ramaswamy, Abhijith Rajaram Rao, et al.The Lancet. Haematology|March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 studyHasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 studyGiorgio Vittorio Scagliotti, Vera Hirsh, Salvatore Siena, et al.World Journal of Otorhinolaryngology - Head and Neck Surgery|May 20, 2020
Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern eraSarbani Ghosh-Laskar, Avinash Pilar, Carlton Johnny, et al.Indian Journal of Surgical Oncology|April 25, 2022
An Audit of Systemic Therapy in Medullary Carcinoma ThyroidAditya Pavan Kumar Kanteti, George Abraham, Vijay M Patil, et al.Journal of Geriatric Oncology|August 6, 2025
Need and uptake of geriatric assessment-guided interventions in older Indian patients with cancer: A cross-sectional analytical studyVanita Noronha, Anupa Pillai, Kartik Mittal, et al.Lung Cancer (Amsterdam, Netherlands)|February 14, 2026
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysisHidetoshi Hayashi, Byoung Chul Cho, Yu Jung Kim, et al.Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Quality of life results from the phase 3 REVEL randomized clinical trial of ramucirumab-plus-docetaxel versus placebo-plus-docetaxel in advanced/metastatic non-small cell lung cancer patients with progression after platinum-based chemotherapyMaurice Pérol, Tudor-Eliade Ciuleanu, Oscar Arrieta, et al.Frontiers in Nuclear Medicine|October 2, 2024
The complementary role of MRI and FET PET in high-grade gliomas to differentiate recurrence from radionecrosisArpita Sahu, Ronny Mathew, Renuka Ashtekar, et al.Clinical Lung Cancer|March 6, 2025
Genomic Profiling of Driver Gene Alterations in Patients With Non-Small Cell Lung Cancer, Patterns of Treatment and Impact on Survival Outcomes: A Single Center Experience of More Than 1200 PatientsMinit Shah, Vanita Noronha, Vijay Patil, et al.Pageof 56